Arlington, MA, United States of America

Zachary Dutton


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Cambridge, MA (US) (2012)
  • Arlington, MA (US) (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Zachary Dutton

Introduction

Zachary Dutton is an accomplished inventor based in Arlington, MA. He has made significant contributions to the field of quantum optics, holding two patents that showcase his innovative approach to technology. His work focuses on the optimal processing of coherent states of light and advancements in quantum detection systems.

Latest Patents

Dutton's latest patents include a "Device and method for optimally distinguishing among an arbitrary set of coherent states of light." This invention involves a method that receives light in a coherent state, splits it into multiple identical states, and processes the quantum information for enhanced performance. Another notable patent is for "Systems and methods for quantum receivers for target detection using a quantum optical radar." This patent describes a quantum-illumination receiver that utilizes a phase-conjugation and mixing system to detect targets effectively.

Career Highlights

Zachary Dutton is currently employed at Raytheon Bbn Technologies Corp., where he continues to push the boundaries of quantum technology. His work has implications for various applications, including advanced radar systems and quantum communication.

Collaborations

Dutton collaborates with esteemed colleagues such as Saikat Guha and Marcus P Da Silva, contributing to a dynamic research environment that fosters innovation.

Conclusion

Zachary Dutton's contributions to quantum optics and technology reflect his dedication to advancing the field. His patents demonstrate a commitment to innovation that could shape the future of quantum applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…